Gilead hikes 2026 sales outlook, says Medicare cuts Biktarvy price by 38% starting in 2028

More in Business

• Wall Street's AI fears slash Google value by $500bn

  Alphabet's aggressive push into artificial intelligence has begun cannibalizing its primary moneymaker by curbing the volume of advertisements sold through standard search queries. Massive capital expenditures dedicated to funding these advanced technologies triggered a rare quarterly cash deficit, intensifying investor panic over whether big tech firms can monetize AI before eroding their established profit centers.

  1 min read
• Amazon gives Wall Street mixed financial picture in earnings report

  The tech giant faced an after-market stock drop exceeding 6% after posting lower net income and trailing quarterly revenue projections. While massive capital spending on artificial intelligence continues to pressure profits, the company is ramping up operations ahead of the holiday shopping season. Markets are scrutinizing whether these multi-billion-dollar investments will deliver sustainable returns amidst high infrastructure costs.

  2 min read
• CCPA penalises Justdial, Sunrise Foods for safety, misleading product claims

  Regulatory scrutiny is intensifying across Indian commerce platforms to safeguard consumer welfare and enforce transparent product descriptions. Authorities acted against unsafe explosive sales listings and deceptive whole-wheat marketing to establish stricter platform accountability. These enforcement measures signal that intermediaries and food brands must independently verify compliance rather than relying on technical disclaimers.

  1 min read